Hospital
Kahuku Medical Center
Kahuku Medical Center was paid $6.47M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99283, emergency room visit (moderate) — 38% of everything it billed.
33Billing provider infoKAHUKU MEDICAL CENTER
KAHUKU, HI 96731
KAHUKU, HI 96731
33aNPI1245430065assigned 07/19/2007
33bProvider typeCritical Access Hospital
28Total paid$6.47M
24GClaims82,099
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Hawaii
Rank by total paid#3 of 8
Median peer was paid$4.91M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,308 | $1.05M | |
| 2019 | 11,552 | $906K | |
| 2020 | 8,212 | $605K | |
| 2021 | 10,694 | $704K | |
| 2022 | 11,884 | $881K | |
| 2023 | 13,378 | $1.03M | |
| 2024incomplete | 13,071 | $1.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 38% | 8,826 | 7,975 | $2.49M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 3,805 | 3,440 | $1.72M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22% | 1,766 | 1,564 | $1.42M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.3% | 1,230 | 1,178 | $215K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.0% | 3,583 | 1,349 | $197K |
| 80061 | Lipid panel | 2.0% | 965 | 917 | $128K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 6,012 | 5,243 | $73K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 31 | 30 | $47K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,131 | 1,049 | $35K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,030 | 1,859 | $23K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,484 | 629 | $17K |
| 97161 | <1% | 100 | 98 | $16K |
55 more codes
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 79 | $13K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,200 | $13K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 14 | $12K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,314 | $10K |
| 80053 | Comprehensive metabolic panel | <1% | 4,532 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,454 | $6K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 158 | $6K |
| 73630 | <1% | 105 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,308 | $4K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,508 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,972 | $4K |
| 87070 | <1% | 220 | $3K | |
| A9270 | Non-covered item or service | <1% | 10,487 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,319 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 805 | $2K |
| 85027 | <1% | 187 | $2K | |
| 84484 | <1% | 1,460 | $801.47 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,197 | $705.96 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 40 | $692.19 |
| 12001 | <1% | 12 | $536.24 | |
| 73030 | <1% | 13 | $441.39 | |
| 80050 | General health panel | <1% | 16 | $319.53 |
| Q3014 | Telehealth originating site facility fee | <1% | 1,932 | $228.96 |
| 84703 | <1% | 945 | $228.59 | |
| 81001 | <1% | 2,893 | $161.48 | |
| 85610 | <1% | 59 | $133.64 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 54 | $131.26 |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,489 | $120.44 |
| 80305 | <1% | 66 | $65.29 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 184 | $51.30 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 777 | $47.54 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 599 | $32.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 2,764 | $30.86 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 70 | $16.78 |
| 80076 | <1% | 13 | $14.85 | |
| 83690 | <1% | 983 | $12.75 | |
| 83735 | <1% | 347 | $5.96 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 28 | $0.03 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 348 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 37 | $0.00 |
| 87040 | 0% | 43 | $0.00 | |
| 85730 | 0% | 12 | $0.00 | |
| 83605 | 0% | 113 | $0.00 | |
| 85651 | 0% | 26 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 12 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 287 | $0.00 |
| 84439 | 0% | 54 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 120 | $0.00 |
| 90715 | 0% | 13 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 48 | $0.00 |
| 85007 | 0% | 258 | $0.00 | |
| 82947 | 0% | 34 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 75 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 29 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVAIOLETI, STEPHANY (CEO)
| Provider | Location | Paid |
|---|---|---|
| Kahuku Medical Center | Kahuku, HI | $1.97M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.